信使 RNA 新冠病毒 2019 疾病（COVID-19）疫苗对医护人员队列中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的有效性。
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
机构信息
Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Clin Infect Dis. 2021 Sep 15;73(6):e1376-e1379. doi: 10.1093/cid/ciab361.
Abstract
In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.
摘要
在一项针对美国大量医疗保健人员的研究中，这些人员均无 2019 年冠状病毒病（COVID-19）既往感染史，共接种了 94382 剂信使 RNA（mRNA）COVID-19 疫苗，其中 49220 剂疫苗为 2 种可获得的 mRNA 疫苗的各 2 剂。这两种 mRNA 疫苗在完成两剂接种后，其调整后的疫苗有效性均超过 96%。
相似文献
1
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.信使 RNA 新冠病毒 2019 疾病（COVID-19）疫苗对医护人员队列中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的有效性。
Clin Infect Dis. 2021 Sep 15;73(6):e1376-e1379. doi: 10.1093/cid/ciab361.
2
Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.台湾地区医护人员接种加强针和流感疫苗对预防 COVID-19 的效果。
Emerg Infect Dis. 2022 Oct;28(10):2126-2130. doi: 10.3201/eid2810.221134. Epub 2022 Aug 29.
3
Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.估算美国加利福尼亚州熟练护理机构医护人员的 COVID-19 疫苗效力。
Emerg Infect Dis. 2022 Aug;28(8):1734-1736. doi: 10.3201/eid2808.220650. Epub 2022 Jun 22.
4
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021.2021 年 2 月至 5 月，美国≥16 岁有症状门诊患者中信使 RNA 疫苗对 2019 年冠状病毒病的有效性。
J Infect Dis. 2021 Nov 22;224(10):1694-1698. doi: 10.1093/infdis/jiab451.
5
The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses.反对延迟严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗加强针接种的理由
Clin Infect Dis. 2021 Oct 5;73(7):1321-1323. doi: 10.1093/cid/ciab070.
6
Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.2019冠状病毒病（COVID-19）mRNA疫苗对无症状医护人员的有效性
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1517-1519. doi: 10.1017/ice.2021.287. Epub 2021 Jun 24.
7
Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.美国有和没有既往 SARS-CoV-2 感染的养老院居民接种一剂 mRNA COVID-19 疫苗后的不良事件。
J Am Med Dir Assoc. 2021 Nov;22(11):2228-2232. doi: 10.1016/j.jamda.2021.08.024. Epub 2021 Aug 28.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain.mRNA 疫苗对西班牙长期护理机构中严重急性呼吸综合征冠状病毒 2 有效性的直接和间接影响
Emerg Infect Dis. 2021 Oct;27(10):2595-2603. doi: 10.3201/eid2710.211184. Epub 2021 Jul 27.
10
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次接种 ChAdOx1 nCoV-19 疫苗后的抗体反应。
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
引用本文的文献
1
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting.辅助治疗中基于免疫的胰腺癌治疗策略
Cancers (Basel). 2025 Apr 7;17(7):1246. doi: 10.3390/cancers17071246.
2
SARS-CoV-2 anti-N antibodies among healthcare personnel without previous known COVID-19.既往无已知新冠病毒病的医护人员中的严重急性呼吸综合征冠状病毒2抗N抗体
Antimicrob Steward Healthc Epidemiol. 2024 Oct 22;4(1):e184. doi: 10.1017/ash.2024.389. eCollection 2024.
3
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review.新冠病毒疫苗对医护人员预防有症状感染和严重感染有效：一项临床综述。
Vaccine X. 2024 Aug 5;20:100546. doi: 10.1016/j.jvacx.2024.100546. eCollection 2024 Oct.
4
Profile of COVID-19 breakthrough cases and its comparison with unvaccinated COVID-19 cases among healthcare workers in a tertiary care centre in North Kerala.喀拉拉邦北部一家三级护理中心医护人员中新冠病毒突破性感染病例概况及其与未接种疫苗的新冠病毒感染病例的比较。
J Family Med Prim Care. 2023 Jun;12(6):1118-1124. doi: 10.4103/jfmpc.jfmpc_1725_22. Epub 2023 Jun 30.
5
Combined Infection Control Interventions Protect Essential Food Workers from Occupational Exposures to SARS-CoV-2 in the Agricultural Environment.联合感染控制干预措施可保护农业环境中的基本食品工人免受 SARS-CoV-2 的职业暴露。
Appl Environ Microbiol. 2023 Jul 26;89(7):e0012823. doi: 10.1128/aem.00128-23. Epub 2023 Jun 13.
6
Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone.混合免疫相较于单独接种疫苗或既往感染过新型冠状病毒肺炎具有保护优势。
Open Forum Infect Dis. 2023 Mar 27;10(5):ofad161. doi: 10.1093/ofid/ofad161. eCollection 2023 May.
7
'Getting the vaccine makes me a champion of it': Exploring perceptions towards peer-to-peer communication about the COVID-19 vaccines amongst Australian adults.“接种疫苗使我成为它的拥护者”：探索澳大利亚成年人对 COVID-19 疫苗的同伴间传播的看法。
Health Expect. 2023 Aug;26(4):1505-1513. doi: 10.1111/hex.13751. Epub 2023 May 3.
8
COVID-19 vaccine effectiveness among healthcare workers: a hospital-based cohort study.COVID-19 疫苗在医护人员中的有效性：一项基于医院的队列研究。
BMJ Open. 2023 May 2;13(5):e068996. doi: 10.1136/bmjopen-2022-068996.
9
Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons, January-November 2021: A Test-Negative Case-Control Analysis Using Surveillance Data.2021年1月至11月美国印第安人和阿拉斯加原住民中COVID-19 mRNA疫苗预防与COVID-19相关的门诊就诊和住院的有效性：一项使用监测数据的检测呈阴性病例对照分析
Open Forum Infect Dis. 2023 Mar 27;10(4):ofad172. doi: 10.1093/ofid/ofad172. eCollection 2023 Apr.
10
Covid-19: virology, variants, and vaccines.新型冠状病毒肺炎：病毒学、变种与疫苗
BMJ Med. 2022 Apr 1;1(1):e000040. doi: 10.1136/bmjmed-2021-000040. eCollection 2022.
本文引用的文献
1
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.英格兰医护人员的 COVID-19 疫苗接种率和 BNT162b2 mRNA 疫苗对感染的有效性（SIREN）：一项前瞻性、多中心、队列研究。
Lancet. 2021 May 8;397(10286):1725-1735. doi: 10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23.
2
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
3
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
4
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
5
The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.免疫实践咨询委员会关于分配 COVID-19 疫苗初始供应的临时建议-美国，2020 年。
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859. doi: 10.15585/mmwr.mm6949e1.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.一线医护人员和普通社区人群 COVID-19 发病风险：前瞻性队列研究。
Lancet Public Health. 2020 Sep;5(9):e475-e483. doi: 10.1016/S2468-2667(20)30164-X. Epub 2020 Jul 31.
8
A Framework for Sustainable Contact Tracing and Exposure Investigation for Large Health Systems.大型医疗系统可持续接触者追踪和暴露调查框架。
Mayo Clin Proc. 2020 Jul;95(7):1432-1444. doi: 10.1016/j.mayocp.2020.05.008. Epub 2020 Jun 16.
9
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
10
Bayesian estimation of vaccine efficacy.疫苗效力的贝叶斯估计。
Clin Trials. 2004;1(3):306-14. doi: 10.1191/1740774504cn025oa.
Zotero 插件